Jubilant Ingrevia commissions new UP facility for Diketene

February 18, 2022 | Friday | News

The commissioned facility has about 7,000 TPA capacity to produce various esters

Image credit: https://jubilantingrevia.com/

Image credit: https://jubilantingrevia.com/

Jubilant Ingrevia has announced the commissioning of its new Diketene derivatives facility at its manufacturing site in North India at Gajraula, Uttar Pradesh.

The newly commissioned facility marks the entry of Jubilant Ingrevia into the fast-growing Diketene business portfolio. This reiterates Jubilant Ingrevia's commitment towards growth through its integrated business model, by providing value-added products and innovative solutions to its customers.

The commissioned facility has about 7,000 TPA capacity to produce various esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate). Jubilant Ingrevia undertakes to commission future phases of Diketene Derivatives as per plan. 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy